Solid Tumors

August 09, 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

June 30, 2020

FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.

November 29, 2019

A new report outlines the sharp cost increase associated with a NSCLC drug’s move from second-line to first-line treatment, and suggests payers work with manufacturers to address treatment pricing.

November 29, 2019

Chemotherapy may be the “boomer” to millennial-esque new cancer treatments, but there is a reason the old standard became that way, and isn’t likely to be replaced anytime soon.

November 25, 2019

There are a lot of ideas about ways to increase the value of cancer care, but personalized treatments may be the most significant and immediate.  

November 25, 2019

A holistic approach provides value and creates plans that support the wide-ranging needs of cancer patients and their families.

November 04, 2019

As the proposed Radiation Oncology Model innovative payment model looms on the horizon, Anne Hubbard, director of health policy for the American Society for Radiation Oncology, talks about the main elements and complex finer points of the model, as well as what it will take for its success.

October 31, 2019

Researchers suggest changing cancer drug regimens could save money without sacrificing quality.

October 30, 2019

Proposed as an alternative to CMS’ Oncology Care Model, the Community Oncology Alliance is developing its Oncology Care Model 2.0 with the hopes of creating a better, more efficient payment and treatment system for cancer care.

October 30, 2019

In order to develop more effective cancer treatments, researchers are turning to precision medicine to evaluate patient tumor responses.